Form 8-K - Current report:
SEC Accession No. 0000912282-15-000447
Filing Date
2015-12-10
Accepted
2015-12-10 13:10:14
Documents
5
Period of Report
2015-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_120815.htm 8-K 66091
2 CERTIFICATE OF DESIGNATIONS ex3_1.htm EX-3.1 132070
3 FORM OF AGENT'S WARRANT ex4_1.htm EX-4.1 79182
4 PRESS RELEASE ex99_1.htm EX-99.1 9688
5 logo.jpg GRAPHIC 6766
  Complete submission text file 0000912282-15-000447.txt   297898
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 151280399
SIC: 2834 Pharmaceutical Preparations